Skip to main content

Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure.

Publication ,  Journal Article
Cosiano, MF; Vista, A; Sun, J-L; Alhanti, B; Harrington, J; Butler, J; Starling, RC; Mentz, RJ; Greene, SJ
Published in: Circ Heart Fail
January 2023

BACKGROUND: Alignment between clinician-reported New York Heart Association (NYHA) class compared and patient-reported outcomes among patients hospitalized for heart failure is unclear. METHODS: ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) was a global randomized trial comparing nesiritide versus placebo among patients hospitalized for heart failure, irrespective of ejection fraction. Among patients with complete baseline data for NYHA class and the patient-reported EuroQOL-5 dimensions ([EQ-5D], both utility index and visual analog scale), levels of each scale were mapped across 4 prespecified categories "best" to "worst." Minor and moderate-severe discordance were defined as NYHA class and EQ-5D differing by 1 level and ≥2 levels, respectively. Multivariable models assessed factors independently associated with moderate-severe discordance, and associations between discordance and clinical outcomes. RESULTS: Among 5741 patients, concordance, minor discordance, and moderate-severe discordance between NYHA class and EQ-5D utility index occurred in 22%, 40%, and 38% of patients, respectively. For NYHA class and EQ-5D visual analog scale, this categorization occurred in 29%, 48%, and 23%. Discordance was more often due to disproportionately higher EQ-5D score (78% of discordance cases with utility index, and 70% with visual analog scale). NYHA class IV, higher EQ-5D scores, race, and geographic region were among patient factors independently associated with moderate-severe discordance. Magnitude of discordance was not associated with clinical outcomes; however, EQ-5D utility index disproportionately worse than NYHA class was associated with increased 180-day mortality (adjusted hazard ratio 1.27 [95% CI, 1.01-1.60]; P=0.04). CONCLUSIONS: In a global trial cohort of patients hospitalized for heart failure, the majority of patients exhibited discordance between clinician-reported NYHA class and patient-reported health status. Multiple patient factors were independently associated with moderate-severe discordance, and patients who perceived their health status as worse than the clinician's perception had higher mortality. Registration: URL: http://www. CLINICALTRIALS: gov; Unique identifier: NCT00475852.

Duke Scholars

Published In

Circ Heart Fail

DOI

EISSN

1941-3297

Publication Date

January 2023

Volume

16

Issue

1

Start / End Page

e010107

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Quality of Life
  • Patient Reported Outcome Measures
  • New York
  • Natriuretic Peptide, Brain
  • Humans
  • Heart Failure
  • Cardiovascular System & Hematology
  • 3208 Medical physiology
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cosiano, M. F., Vista, A., Sun, J.-L., Alhanti, B., Harrington, J., Butler, J., … Greene, S. J. (2023). Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure. Circ Heart Fail, 16(1), e010107. https://doi.org/10.1161/CIRCHEARTFAILURE.122.010107
Cosiano, Michael F., Andrew Vista, Jie-Lena Sun, Brooke Alhanti, Josephine Harrington, Javed Butler, Randall C. Starling, Robert J. Mentz, and Stephen J. Greene. “Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure.Circ Heart Fail 16, no. 1 (January 2023): e010107. https://doi.org/10.1161/CIRCHEARTFAILURE.122.010107.
Cosiano MF, Vista A, Sun J-L, Alhanti B, Harrington J, Butler J, et al. Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure. Circ Heart Fail. 2023 Jan;16(1):e010107.
Cosiano, Michael F., et al. “Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure.Circ Heart Fail, vol. 16, no. 1, Jan. 2023, p. e010107. Pubmed, doi:10.1161/CIRCHEARTFAILURE.122.010107.
Cosiano MF, Vista A, Sun J-L, Alhanti B, Harrington J, Butler J, Starling RC, Mentz RJ, Greene SJ. Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure. Circ Heart Fail. 2023 Jan;16(1):e010107.

Published In

Circ Heart Fail

DOI

EISSN

1941-3297

Publication Date

January 2023

Volume

16

Issue

1

Start / End Page

e010107

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Quality of Life
  • Patient Reported Outcome Measures
  • New York
  • Natriuretic Peptide, Brain
  • Humans
  • Heart Failure
  • Cardiovascular System & Hematology
  • 3208 Medical physiology
  • 3201 Cardiovascular medicine and haematology